Savas B - Search Results

1

Correlation of serum proteomics patterns of sCD200 (OX-2), sApo-2L (sTRAIL), vitamin-D and homocysteine to quantitative FDG-PET/CT findings in newly diagnosed non-small cell lung cancer.

Bisgnin A, Yalcin AD, Gumuslu S, Kargi B, Kargi A, Savas B, Strauss LG. Bisgnin A, et al. Among authors: savas b. J BUON. 2013 Oct-Dec;18(4):1099-100. J BUON. 2013. PMID: 24344047 No abstract available.

2

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer.

Bisgin A, Kargi A, Yalcin AD, Aydin C, Ekinci D, Savas B, Sanlioglu S. Bisgin A, et al. Among authors: savas b. BMC Cancer. 2012 Feb 7;12:58. doi: 10.1186/1471-2407-12-58. BMC Cancer. 2012. PMID: 22313795 Free PMC article.

3

The importance of COX-2 expression as prognostic factor in early breast cancer.

Kargi A, Uysal M, Bozcuk H, Coskun HS, Savas B, Ozdogan M. Kargi A, et al. Among authors: savas b. J BUON. 2013 Jul-Sep;18(3):579-84. J BUON. 2013. PMID: 24065467 Free article.

4

The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.

Ekinci D, Kargi A, Yalcin AD, Savas B. Ekinci D, et al. Among authors: savas b. J BUON. 2013 Jan-Mar;18(1):245-52. J BUON. 2013. PMID: 23613412 Free article.

5

IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer.

Kargi A, Yalcin AD, Erin N, Savas B, Polat HH, Gorczynski RM. Kargi A, et al. Among authors: savas b. Clin Lab. 2012;58(5-6):501-5. Clin Lab. 2012. Corrected and republished in: Clin Lab. 2012;58(9-10):1103-7. PMID: 22783581 Corrected and republished.

6

Erratum to "IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer" [Clin. Lab. 2012; 58:501-505].

Kargi A, Yalcin AD, Erin N, Savas B, Polat HH, Gorczynski RM. Kargi A, et al. Among authors: savas b. Clin Lab. 2012;58(9-10):1103-7. Clin Lab. 2012. PMID: 23163132

7

Interaction of allergic disease and (immune) response to cancer in patient with stage-4 adenocarcinoma of the lung.

Yalcin AD, Kargi A, Savas B, Gorczynski RM. Yalcin AD, et al. Among authors: savas b. Clin Lab. 2012;58(11-12):1329-30. Clin Lab. 2012. PMID: 23289208

8

Leukocytosis, thrombocytosis and hypercalcemia as a triple paraneoplastic syndrome in a patient with squamous cell carcinoma of the renal pelvis.

Coşkun HŞ, Kargı A, Özdoğan M, Bozcuk H, Savaş B. Coşkun HŞ, et al. Among authors: savas b. Turk J Haematol. 2010 Mar 5;27(1):51-2. Turk J Haematol. 2010. PMID: 27265802 English. No abstract available.

9

Quality of life in patients with advanced non-small cell lung cancer.

Bozcuk H, Dalmis B, Samur M, Ozdogan M, Artac M, Savas B. Bozcuk H, et al. Among authors: savas b. Cancer Nurs. 2006 Mar-Apr;29(2):104-10. doi: 10.1097/00002820-200603000-00004. Cancer Nurs. 2006. PMID: 16565619

10

Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer.

Tatli AM, Arslan D, Uysal M, Goksu SS, Gunduz SG, Coskun HS, Ozdogan M, Savas B, Bozcuk HS. Tatli AM, et al. Among authors: savas b. J Cancer Res Ther. 2015 Oct-Dec;11(4):805-9. doi: 10.4103/0973-1482.146092. J Cancer Res Ther. 2015. PMID: 26881522 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters